BamSEC and AlphaSense Join Forces
Learn More

Brainstorm Cell Therapeutics Inc. – Material Contracts

OTC: BCLI    
Share price (6/12/26): $0.75    
Market cap (6/12/26): $8.277 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 18 pages Brainstorm Cell Therapeutics Inc. Indemnification Agreement
12/34/56
EX-10.107
from S-1 39 pages Securities Purchase Agreement
12/34/56
EX-10.4
from 10-Q 22 pages Common Stock Purchase Warrant Brainstorm Cell Therapeutics Inc
12/34/56
EX-10.3
from 10-Q 39 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 10-Q 14 pages The Issue Price of This Note Is $151,800.00 the Original Issue Discount Is $19,800.00
12/34/56
EX-10.1
from 10-Q 12 pages Securities Purchase Agreement
12/34/56
EX-10.15
from 8-K 1 page Brainstorm Cell Therapeutics Inc. Amendment No. 6 to 2014 Global Share Option Plan
12/34/56
EX-10.8
from 8-K 1 page Brainstorm Cell Therapeutics Inc. Amendment No. 6 to 2014 Stock Incentive Plan
12/34/56
EX-10.1
from 8-K 43 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 42 pages Securities Purchase Agreement
12/34/56
EX-10.6
from 8-K 19 pages Promissory Note
12/34/56
EX-10.5
from 8-K 29 pages Securities Purchase Agreement
12/34/56
EX-10.4
from 8-K 20 pages Convertible Promissory Note
12/34/56
EX-10.3
from 8-K 26 pages Note Purchase Agreement
12/34/56
EX-10.2
from 8-K 15 pages The Issue Price of This Note Is $94,300.00 the Original Issue Discount Is $12,300.00
12/34/56
EX-10.1
from 8-K 12 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 15 pages Promissory Note
12/34/56
EX-10.1
from 8-K 22 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 15 pages The Issue Price of This Note Is $182,400.00 the Original Issue Discount Is $22,400.00
12/34/56
EX-10.1
from 8-K 12 pages Securities Purchase Agreement
12/34/56